Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,623 | 2,652 | 4,200 | 98,466 | 8,075 |
| Operating Income | -4,623 | -2,652 | -4,200 | -98,466 | -8,075 |
| Other Income | 243 | 210 | 176 | 207 | 138 |
| Pre-tax Income | -4,380 | -2,442 | -4,025 | -98,259 | -7,937 |
| Net Income Continuous | -4,380 | -2,442 | -4,025 | -98,259 | -7,937 |
| Net Income | $-4,380 | $-2,442 | $-4,025 | $-98,259 | $-7,937 |
| EPS Basic Total Ops | -1.34 | 28.30 | -2.32 | -86.72 | -7.25 |
| EPS Basic Continuous Ops | -1.34 | 28.31 | -2.32 | -86.72 | -7.25 |
| EPS Diluted Total Ops | -1.34 | 28.30 | -2.32 | -86.72 | -7.25 |
| EPS Diluted Continuous Ops | -1.34 | 28.31 | -2.32 | -86.72 | -7.25 |
| EBITDA(a) | $-4,622 | $-2,654 | $-4,139 | $-98,402 | $-8,011 |